|
"Infections, immunity, and inflammation in cancer"
|
Z01 CP010150
|
$726,292
|
$58,635
|
Engels
|
DCEG (NCI)
|
|
ABC Transporters in Human Disease and Multidrug Resistance
|
Z01 BC 005725
|
$505,750
|
$50,575
|
Dean, Michael
|
CCR (NCI)
|
|
Analysis of Pathways that Suppress or Accelerate Premalignant Progression and Mal
|
Z01 BC 005445
|
$687,001
|
$20,610
|
Yuspa, Stuart
|
CCR (NCI)
|
|
Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS
|
Z01 SC 004020
|
$1,324,087
|
$132,409
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Bio-Therapies for the Treatment of Cancer and Infectious Disease
|
Z01 BC 008757
|
$566,122
|
$226,449
|
FitzGerald, David
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
Z01 BC 010030
|
$722,377
|
$72,238
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Chromatin Structure and Gene Expression
|
Z01 BC 005450
|
$444,044
|
$133,213
|
Hager, Gordon
|
CCR (NCI)
|
|
Clinical Pharmacogenetics
|
Z01 BC 010627
|
$102,568
|
$51,284
|
Figg, William
|
CCR (NCI)
|
|
Clinical Trials with Immunotoxins
|
Z01 BC 010020
|
$455,118
|
$22,756
|
Pastan, Ira
|
CCR (NCI)
|
|
Design of Drugs Against Cancer and Viral Diseases
|
Z01 BC 010347
|
$662,690
|
$132,538
|
Michejda, Christopher
|
CCR (NCI)
|
|
Development of Angiogenesis Inhibitors
|
Z01 SC 006538
|
$102,568
|
$61,541
|
Figg, William
|
CCR (NCI)
|
|
Development of Drugs That Target Prostate Cancer
|
Z01 BC 010547
|
$25,642
|
$25,642
|
Figg, William
|
CCR (NCI)
|
|
Diazeniumdiolate Chemistry as a Platform for Designing Nitric Oxide-Based Therapi
|
Z01 BC 005673
|
$776,194
|
$155,239
|
Keefer, Larry
|
CCR (NCI)
|
|
Discovering Disease Susceptibility Genes in African Americans
|
Z01 BC 005800
|
$77,824
|
$77,824
|
Smith, Michael
|
CCR (NCI)
|
|
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
|
Z01 BC 006150
|
$399,830
|
$79,966
|
Pommier, Yves
|
CCR (NCI)
|
|
Enzyme Inhibitors as Potential Anticancer and Antiviral Drugs
|
Z01 BC 006176
|
$311,124
|
$62,225
|
Marquez, Victor
|
CCR (NCI)
|
|
Family Studies
|
Z01 CP004410
|
$2,848,830
|
$5,570
|
Tucker
|
DCEG (NCI)
|
|
Function of Steroid Receptors in Subcellular Compartments
|
Z01 BC 010027
|
$197,353
|
$59,206
|
Hager, Gordon
|
CCR (NCI)
|
|
Functional Analysis of Cancer Genes from Human Chromosome 3p
|
Z01 BC 008579
|
$239,875
|
$23,988
|
Lerman, Michael
|
CCR (NCI)
|
|
Gene Discovery
|
Z01 BC 010298
|
$910,236
|
$273,071
|
Pastan, Ira
|
CCR (NCI)
|
|
Gene Methylation in Prostate Cancer
|
Z01 BC 010459
|
$193,778
|
$193,778
|
Woodson, Karen
|
CCR (NCI)
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
Z01 BC 005598
|
$849,668
|
$42,483
|
Gottesman, Michael
|
CCR (NCI)
|
|
High-Density Marker Studies Near Founder BRCA1/2 Mutations
|
Z01 BC 010472
|
$37,410
|
$7,482
|
Struewing, Jeffery
|
CCR (NCI)
|
|
Human Monoclonal Antibodies and Antibody-Guided Nanoparticles
|
Z01 BC 010701
|
$788,451
|
$157,690
|
Dimitrov, Dimiter
|
CCR (NCI)
|
|
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer
|
Z01 BC 010453
|
$102,568
|
$102,568
|
Figg, William
|
CCR (NCI)
|
|
In vivo Imaging Analysis of Steroid/Nuclear Receptor Function
|
Z01 BC 010308
|
$246,691
|
$49,338
|
Hager, Gordon
|
CCR (NCI)
|
|
In Vivo MRI imaging of single metastatic cells
|
Z01 BC 010731
|
$105,828
|
$26,457
|
Kelly, Kathleen
|
CCR (NCI)
|
|
Inflammation and Prostatic Carcinogenesis
|
Z01 BC 010653
|
$90,965
|
$90,965
|
Hurwitz, Arthur
|
CCR (NCI)
|
|
Investigation of Germ-line Genetic Variation and Susceptibility to Cancer and its
|
Z01 SC 010083
|
$618,227
|
$123,645
|
Chanock, Stephen
|
CCR (NCI)
|
|
Matriptase Inhibitory Agents as Anti-metastatics
|
Z01 BC 010703
|
$19,520
|
$5,856
|
Roller, Peter
|
CCR (NCI)
|
|
Mechanisms of Inorganic Carcinogenesis
|
Z01 BC 005488
|
$1,003,133
|
$200,627
|
Waalkes, Michael
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
Z01 BC 010830
|
$364,144
|
$18,207
|
Gottesman, Michael
|
CCR (NCI)
|
|
Modulating T cell tolerance to elicit tumor immunity and autoimmunity
|
Z01 BC 010563
|
$363,861
|
$145,544
|
Hurwitz, Arthur
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
Z01 BC 010738
|
$713,420
|
$71,342
|
Hou, Steven
|
CCR (NCI)
|
|
Molecular Mechanism of Action of Phorbol Ester
|
Z01 BC 005270
|
$1,250,284
|
$187,543
|
Blumberg, Peter
|
CCR (NCI)
|
|
Molecular Mechanisms of Growth Factor Modulated Proliferation
|
Z01 BC 010253
|
$467,624
|
$233,812
|
Farrar, William
|
CCR (NCI)
|
|
Molecular Pathology of Cancer
|
Z01 SC 010437
|
$411,871
|
$288,309
|
Emmert-Buck, Michael
|
CCR (NCI)
|
|
Molecular-targeted Radiation Therapy
|
Z01 BC 010670
|
$426,595
|
$85,319
|
Coleman, C. Norman
|
CCR (NCI)
|
|
New Strategies for Cancer Drug Discovery: Integrative Pharmacogenomics and Pharm
|
Z01 BC 007349
|
$606,047
|
$60,605
|
Weinstein, John
|
CCR (NCI)
|
|
Peptide-based Inhibitors of HDM2 Protein
|
Z01 BC 007354
|
$19,520
|
$4,880
|
Roller, Peter
|
CCR (NCI)
|
|
Prolactin Interactions in Mammary Gland Development and Tumorigenesis
|
Z01 BC 008226
|
$641,943
|
$32,097
|
Vonderhaar, Barbara
|
CCR (NCI)
|
|
Prostate Cancer Imaging
|
Z01 BC 010655
|
$373,930
|
$373,930
|
Choyke, Peter
|
CCR (NCI)
|
|
Prostate stem cells and cancer stem cells
|
Z01 BC 010695
|
$153,898
|
$153,898
|
Vogel, Jonathan
|
CCR (NCI)
|
|
Ras-mediated signals in human epithelial cell transformation and metastasis
|
Z01 BC 010607
|
$211,656
|
$126,993
|
Kelly, Kathleen
|
CCR (NCI)
|
|
Role of Gene Methylation in Tumor Microenvironment
|
Z01 BC 010669
|
$96,889
|
$96,889
|
Woodson, Karen
|
CCR (NCI)
|
|
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
|
Z01 SC 010074
|
$780,992
|
$195,248
|
Neckers, Leonard
|
CCR (NCI)
|
|
Role of Selenium in Cancer and Health
|
Z01 BC 005317
|
$612,024
|
$91,804
|
Hatfield, Dolph
|
CCR (NCI)
|
|
Signal Transduction Events and the Regulation of Cell Growth
|
Z01 SC 006743
|
$441,718
|
$154,601
|
Trepel, Jane
|
CCR (NCI)
|
|
Structural Studies of Drug Agents by Nuclear Magnetic Resonance Spectroscopy
|
Z01 BC 010739
|
$106,609
|
$53,304
|
Barchi, Joseph
|
CCR (NCI)
|
|
Technology Development
|
Z01 BC 010729
|
$411,871
|
$123,561
|
Emmert-Buck, Michael
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $6,633,980
|